Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients: a meta-analysis of multicenter randomized controlled trials
Eros Pilia, Alessandro Belletti, Stefano Fresilli, et al.
Journal of Thrombosis and Thrombolysis (2022) Vol. 54, Iss. 3, pp. 420-430
Open Access | Times Cited: 20

Showing 20 citing articles:

Lessons we learned during the past four challenging years in the COVID-19 era: pharmacotherapy, long COVID complications, and vaccine development
Parisa Ghasemiyeh, Soliman Mohammadi‐Samani
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical Trials
Konstantinos G. Kyriakoulis, Evangelos Dimakakos, Ioannis Kyriakoulis, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 20, pp. 5997-5997
Open Access | Times Cited: 19
The Effect of Heparin Full-Dose Anticoagulation on Survival of Hospitalized, Non-critically Ill COVID-19 Patients: A Meta-analysis of High Quality Studies
Eros Pilia, Alessandro Belletti, Stefano Fresilli, et al.
Lung (2023) Vol. 201, Iss. 2, pp. 135-147
Open Access | Times Cited: 10
Coagulopathy and thromboembolic events a pathogenic mechanism of COVID‐19 associated with mortality: An updated review
Parastoo Yousefi, Saber Soltani, Goli Siri, et al.
Journal of Clinical Laboratory Analysis (2023) Vol. 37, Iss. 11-12
Open Access | Times Cited: 7
D-dimer levels in non-COVID-19 ARDS and COVID-19 ARDS patients: A systematic review with meta-analysis
Krisztina Tóth, Stefano Fresilli, Nicola Paoli, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0277000-e0277000
Open Access | Times Cited: 6
Evaluation of a fast‐and‐frugal clinical decision algorithm (‘pathways’) on clinical outcomes in hospitalised patients with COVID‐19 treated with anticoagulants
Benjamin Djulbegović, Iztok Hozo, David Lizarraga, et al.
Journal of Evaluation in Clinical Practice (2022) Vol. 29, Iss. 1, pp. 3-12
Open Access | Times Cited: 9
Safety and efficacy of antithrombotics in outpatients with symptomatic COVID-19: A systematic review and meta-analysis
Saad Ali Ansari, Nooraldin Merza, Madiha Salman, et al.
Current Problems in Cardiology (2024) Vol. 49, Iss. 4, pp. 102451-102451
Closed Access | Times Cited: 1
Major Bleeding Events in Hospitalized COVID-19 Patients: A Retrospective Observational Study
Andrea Poloni, Giacomo Casalini, Giacomo Pozza, et al.
Medicina (2024) Vol. 60, Iss. 5, pp. 814-814
Open Access | Times Cited: 1
Risk of venous thromboembolism in COVID‐19 infection
M. Honkanen, Simo Sirkeoja, Hanna Viskari, et al.
Internal Medicine Journal (2023) Vol. 53, Iss. 8, pp. 1478-1480
Open Access | Times Cited: 4
Estimated plasma volume status in COVID-19 patients and its relation to comorbidities and clinical outcomes
Marko Lucijanić, Ivan Krečak, Iva Bušić, et al.
Journal of Thrombosis and Thrombolysis (2023) Vol. 57, Iss. 1, pp. 50-57
Closed Access | Times Cited: 3
Therapeutic-dose anticoagulation or thromboprophylaxis with low-molecular-weight heparin for moderate Covid-19: meta-analysis of randomized controlled trials
Javier Ena, Victoria Valls
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 4, pp. 1189-1196
Open Access | Times Cited: 4
Alteplase in COVID-19 severe hypoxemic respiratory failure: the TRISTARDS multicenter randomized trial
Giovanni Landoni, Pratima Chowdary, Ferhat Meziani, et al.
Annals of Intensive Care (2024) Vol. 14, Iss. 1
Open Access
COVID-19 Associated Micro-Anastomotic Thrombosis After Abdominal Free Tissue Transfer: A Case Report and Literature Review
Peter Vonu, Rachel Safeek, Kalyan Dadireddy, et al.
Plastic Surgery (2023) Vol. 31, Iss. 4, pp. 408-412
Open Access | Times Cited: 1
Drug prescription patterns and their association with mortality and hospitalization duration in COVID-19 patients: insights from big data
Reza Mehrizi, Ali Golestani, Mohammad‐Reza Malekpour, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 1
Safety of Pharmacotherapy in COVID-19 Patients: A Literature Review
А. V. Kryukov, A. S. Zhiryakova, Yu. V. Shevchuk, et al.
Safety and Risk of Pharmacotherapy (2022) Vol. 10, Iss. 4, pp. 326-344
Open Access | Times Cited: 2
Different death rates between COVID-19 waves among unvaccinated patients: moving beyond lessons learned
Davide Campagna, Crsitina Russo, Elisa Trovato, et al.
Internal and Emergency Medicine (2022) Vol. 18, Iss. 1, pp. 7-9
Open Access | Times Cited: 1
Y-site Injection Physical Compatibility of Remdesivir with Select Intravenous Drugs Used in Palliative Care and for Treating Coronavirus Disease 2019
Masayoshi Kondo, Mai Gempei, Kei Watanabe, et al.
Journal of Nippon Medical School (2023) Vol. 90, Iss. 5, pp. 381-386
Open Access
Enoxaparin for COVID-19: a systematic review and meta-analysis of randomized controlled trials
Muhammad Ehsan, Uzair Jafar, Momina Butt, et al.
Journal of Thrombosis and Thrombolysis (2023) Vol. 56, Iss. 3, pp. 495-498
Closed Access
Thromboembolische Erkrankungen aus hämostaseologischer Sicht
Bernd Pötzsch
DMW - Deutsche Medizinische Wochenschrift (2023) Vol. 148, Iss. 14, pp. 883-889
Closed Access
Thromboelastography-Guided Anticoagulation in Critically Ill COVID-19 Patients: Mortality and Bleeding Outcomes
Sean Michael Duenas, Juliana Derfel, Margaret Gorlin, et al.
Journal of Respiration (2023) Vol. 4, Iss. 1, pp. 1-11
Open Access
Page 1

Scroll to top